Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy

Journal of Neuroimmunology

Volumn 276, Issue 1-2, 2014, Pages 207-212

  Notturno, Francesca ^a   Di Febo, Tiziana ^b   Yuki, Nobuhiro ^c   Fernandez Rodriguez, Blanca M ^d   Corti, Davide ^d   Nobile Orazio, Eduardo ^e   Carpo, Marinella ^f   De Lauretis, Angelo ^g   Uncini, Antonino ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Veterinary Medical Research Inst for Abruzzo and Molise G Caporale   (Italy)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^e UNIVERSITY OF MILAN   (Italy)

^f TREVIGLIO HOSPITAL   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chronic inflammatory demyelinating neuropathy; Gliomedin; Multifocal motor neuropathy; Neurofascin

Indexed keywords

ANTIBODY; GANGLIOSIDE GM1 ANTIBODY; GLIOMEDIN; GLIOMEDIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NERVE CELL ADHESION MOLECULE; NEUROFASCIN 186; NEUROFASCIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; CELL ADHESION MOLECULE; GANGLIOSIDE GM1; GLDN PROTEIN, HUMAN; ISOPROTEIN; MEMBRANE PROTEIN; NERVE GROWTH FACTOR; NERVE PROTEIN; NFASC PROTEIN, HUMAN;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SCHOOL CHILD; STAINING; VERY ELDERLY; ANIMAL; BIOLOGY; BLOOD; COMPLICATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; MOTOR NEURON DISEASE; POLYNEUROPATHY;

ANIMALS; AUTOANTIBODIES; CELL ADHESION MOLECULES; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M1) GANGLIOSIDE; HUMANS; MALE; MEMBRANE PROTEINS; MOTOR NEURON DISEASE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; POLYNEUROPATHIES; PROTEIN ISOFORMS; RATS; TRANSFECTION;

EID: 84908546515     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.09.001     Document Type: Article

References (21)

1. Caporale C.M., Papola F., Fioroni M.A., Aureli A., Giovannini A., Notturno F., Adorno D., Caporale V., Uncini A. Susceptibility to Guillain-Barré is associated to polymorphisms of CD1 genes. J. Neuroimmunol. 2006, 177:112-118.
2. Devaux J.J., Odaka M., Yuki N. Nodal proteins are target antigens in Guillain-Barré syndrome. J. Peripher. Nerv. Syst. 2012, 17:62-71.
3. Eshed Y., Feinberg K., Poliak S., Sabanay H., Sarig-Nadir O., Spiegel I., Bermingham J.R., Peles E. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron 2005, 47:215-229.
4. European Federation of Neurological Societies Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision 2010, 15:295-301.
5. Hirota N., Kaji R., Bostock H., Shindo K., Kawasaki T., Mizutani K., Oka N., Kohara N., Saida T., Kimura J. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 1997, 120:2159-2169.
6. Hughes R.A. Chronic inflammatory demyelinating polyradiculoneuropathy. J. Clin. Immunol. 2010, 30(Suppl. 1):S70-S73.
7. Li J., Bai Y., Ghandour K., Qin P., Grandis M., Trostinskaia A., Ianakova E., Wu X., Schenone A., Vallat J.M., Kupsky W.J., Hatfield J., Shy M.E. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 2005, 128:1168-1177.
8. Lonigro A., Devaux J.J. Disruption of neurofascin and gliomedin at node of Ranvier precedes demyelination in experimental allergic neuritis. Brain 2009, 132:260-273.
9. Mathey E.K., Derfuss T., Storch M.K., Williams K.R., Hales K., Woolley D.R., Al-Hayani A., Davies S.N., Rasband M.N., Olsson T., Moldenhauer A., Velhin S., Hohlfeld R., Meinl E., Linington C. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 2007, 204:2363-2372.
10. Ng J.K., Malotka J., Kawakami N., Derfuss T., Khademi M., Olsson T., Linington C., Odaka M., Tackenberg B., Prüss H., Schwab J.M., Harms L., Harms H., Sommer C., Rasband M.N., Eshed-Eisenbach Y., Peles E., Hohlfeld R., Yuki N., Dornmair K., Meinl E. Neurofascins as a target autoaantibodies in peripheral neuropathies. Neurology 2012, 79:2241-2248.
11. Notturno F., Luciani M., Caporale C.M., Ciarelli A., Uncini A. Antibodies to ganglioside complexes in Guillain-Barré syndrome: clinical correlates, fine specificity and complement activation. Int. J. Immunopathol. Pharmacol. 2009, 22:437-445.
12. Olney R.K., Lewis R.A., Putnam T.D., Campellone J.V. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003, 27:117-121.
13. Ratcliffe C.F., Westenbroek R.E., Curtis R., Catterall W.A. Sodium channel β1 and β3 subunits associate with neurofascin through their extracellular immunoglobulin-like domain. J. Cell Biol. 2001, 154:427-434.
14. Ren Q., Bennett V. Palmitoylation of neurofascin at a site in the membrane-spanning domain highly conserved among the L1 family of cell adhesion molecules. J. Neurochem. 1998, 70:1839-1849.
15. Robinson W.H., Fontoura P., Lee B.J., de Vegvar H.E., Tom J., Pedotti R., Di Gennaro C.D., Mitchell D.J., Fong D., Ho P.P., Ruiz P.J., Maverakis E., Stevens D.B., Bernard C.C., Martin R., Kuchroo V.K., van Noort J.M., Genain C.P., Amor S., Olsson T., Utz P.J., Garren H., Steinman L. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 2003, 21:1033-1039.
16. Saporta M.A., Katona I., Lewis R.A., Masse S., Shy M.E., Li J. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Brain 2009, 132:3263-3273.
17. Sherman D.L., Tait S., Melrose S., Johnson R., Zonta B., Court F.A., Macklin W.B., Meek S., Smith A.J., Cottrell D.F., Brophy P.J. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 2005, 48:737-742.
18. Susuki K., Rasband M.N., Tohyama K., Koibuchi K., Okamoto S., Funakoshi K., Hirata K., Baba H., Yuki N. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 2007, 27(15):3956-3967.
19. Takigawa T., Yasuda H., Kikkawa R., Shigeta Y., Saida T., Kitasato H. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann. Neurol. 1995, 37(4):436-442.
20. Uncini A., Santoro M., Corbo M., Lugaresi A., Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993, 16:610-615.
21. Vlam L., van der Pol W.L., Cats E.A., Straver D.C., Piepers S., Franssen H., van den Berg L.H. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat. Rev. Neurol. 2011, 8:48-58.